ACM
LUNG icon

Atika Capital Management’s Pulmonx LUNG Stock Holding History

Atika Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-101,700
Closed -$4.65M – 105
2021
Q1 		$4.65M Sell
101,700
-9,900
-9% -$568K 0.4% 78
2020
Q4 		$7.7M Buy
+111,600
New +$5.47M 0.6% 70

Other funds holding LUNG

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Atika Capital Management's LUNG Position: Q2 2021 in Review

Atika Capital Management sold out of Pulmonx (LUNG) in Q2 2021, closing a stake of 101,700 shares — an estimated $4.65M sold.

Atika Capital Management first reported a position in LUNG in Q4 2020 and held it in 2 quarters. The position peaked at $7.7M in Q4 2020. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2021.

  • Atika Capital Management reported no remaining Pulmonx position as of Q2 2021 after selling out during the quarter.
  • Atika Capital Management sold 101,700 Pulmonx shares in Q2 2021, an estimated $4.65M.
  • Atika Capital Management first reported a position in Pulmonx in Q4 2020 and held it in 2 quarters.
  • Atika Capital Management's Pulmonx position peaked at $7.7M in Q4 2020.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2021.

Based on Atika Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.